Loading product literature...
Citrate phosphate (McIlvaine) buffers and related citrate phosphate–based formulations, including McIlvaine, CPD, and CPDA, provide stable, pH-controlled environments for biochemical, analytical, and clinical workflows. These solutions rely on the combined buffering chemistry of citric acid and sodium phosphate, supporting applications ranging from enzyme assays and protein stabilization to red blood cell collection and long-term blood preservation.
McIlvaine Buffer
Developed by Theodore McIlvaine in 1921, McIlvaine buffer is a standardized citrate-phosphate buffer system prepared by mixing disodium phosphate and citric acid solutions in varying ratios to produce a broad pH range from ~2.6 to 8.0 [1]. Its clarity, reproducibility, and minimal chemical reactivity make it a preferred buffer in both research and clinical laboratories.
Key Features:
Applications:
CPD is an anticoagulant solution consisting of citric acid, sodium citrate, monobasic sodium phosphate, and dextrose. It is formulated specifically for blood preservation, preventing clotting, and providing metabolic support to red blood cells.

Key Features:
Applications:
A similar product, Acid-Citrate-Dextrose (ACD) Solution, is routinely used in cell processing, blood storage, platelet collection, laboratory tests and blood-related research labs.
1. Define your application
Identify whether your work involves:
2. Match pH range to your intended use
3. Check compatibility
Citric acid chelates metals like Ca²⁺ and Mg²⁺.
If working with metal-dependent enzymes, supplementation or alternative buffers may be required.
4. Select appropriate purity and formulation
For bioprocessing, choose:
This ensures batch-to-batch consistency.
Tips
Citrate-phosphate (McIlvaine) buffers, CPD, and CPDA solutions support a wide spectrum of laboratory and clinical activities, from precise analytical buffering to maintaining red blood cell viability during storage. Choosing the right solution ensures optimal pH stability, reproducibility, and compatibility with your workflow.
Explore our Citrate-Phosphate & McIlvaine Buffers
Request Custom CPD/CPDA Solutions
Citrate-Phosphate-Dextrose-Adenine Solution is a modified formulation of CPD, with increased Dextrose concentration and the addition of Adenine, a purine nucleobase. These modifications have been found to increase blood viability during storage, specifically after longer-term storage.[2] In addition, Beutler and West found that CPDA-1 is superior for “hard-packed” blood with concentrations of hematocrit greater than 80 percent.
CAT# | Product Name |
|---|---|
Citrate-Phosphate-Dextrose-Adenine (CPDA-1) Solution |
Application | Recommended Solution | Notes |
|---|---|---|
Enzyme and protein assays | Broad pH adjustability; excellent for metal-sensitive systems and enzyme kinetics. | |
pH calibration standards | Offers consistent, reproducible pH values across acidic to near-neutral ranges. | |
Blood collection and storage | Prevents coagulation, maintains red cell viability, supports both short- and long-term storage. | |
Histology and tissue processing | Provides stable pH during staining, fixation, and colorimetric workflows. | |
Bioprocess and formulation studies | Reliable buffering capacity across temperature shifts and formulation environments. |
Troubleshooting
Issue | Possible Cause | Recommended Action |
|---|---|---|
pH drift over time | Incorrect citrate/phosphate ratio; temperature variation | Recheck formulation, adjust pH at experimental temperature. |
Reduced enzyme activity | Citrate chelation depleting essential metals | Use non-chelating buffer or supplement required ions. |
Precipitate formation | Salt incompatibility or evaporation | Prepare fresh buffer; filter if needed; store tightly capped. |
Blood cell degradation (CPD/CPDA) | Storage temperature too high or expired solution | Maintain RBC units at 1–6 °C and verify expiration dates. |